<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04123964</url>
  </required_header>
  <id_info>
    <org_study_id>7368</org_study_id>
    <nct_id>NCT04123964</nct_id>
  </id_info>
  <brief_title>β-lactam Use in Single-stage Exchange of ProstheTic Infections (Knee / Hip) in a Center of Reference (β-SEPTIC)</brief_title>
  <acronym>β-SEPTIC</acronym>
  <official_title>Use of Probabilist Broad-spectrum β-lactam for One-stage Replacement of Infected Hip / Knee Arthroplasties: Retrospective Analysis in a Center of Reference</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to the official recommendations, infected prosthesis can be surgically treated by
      one or two-stage replacement. In Strasbourg, the investigators only perform one-stage
      surgery, which means that the new materiel is put directly into an infected site. To prevent
      re-infection, probabilist antibiotherapy has to be started the earlier as possible and to
      have the larger specter as possible. Official recommendations don't specify the best choice
      of antibiotherapy and let prescriptors make choice, according to the local epidemiology and
      patient's history.

      In Strasbourg, the investigators systematically start an antibiotic against cocci gram
      positive: daptomycin. Sometimes, the investigators add tazocillin, a broad-spectrum β-lactam
      against bacillus gram negative. To determine if the investigators use the second one, they
      focalized on the presence of fistula or not. Indeed, enterobacteriae from gastro-intestinal
      tractus are also found on the skin and can move to the peri-prosthetic site if a fistula is
      created. The major disadvantage of this board-spectrum antibiotic is the selection and
      creation of resistant bacteriae, which can be responsible of failure, re-infection, or just
      spreading on the environnement.

      The primary purpose is to evaluate retrospectively the prescription of tazocillin, judging
      it's necessity thanks to antibiograms performed on samples taken during surgery. The aim is
      to evaluate if the criteria &quot; fistula or not &quot; is a good one to guide the prescription of
      board-spectrum β-lactam.

      Secondary purposes are to find the etiology of failures ( bacteriological failure or
      re-infection with a new pathogen), evaluate the apparition of multi-drug resistant bacteriae
      and infections they are responsible for, looking for others criterias which could help the
      investigators to choose the probablist antibiotherapy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective study of the use of β-lactams in infected of hip or knee prosthesis</measure>
    <time_frame>Files analysed retrospectily from January 1st, 2018 to December 31st, 2018 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infected of Hip or Kneeprosthesis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults ( &gt; 18 years-old) hospitalized from 1st January 2018 to 31th December 2018 in the
        septic orthopedic surgery unity of the university hospital of Strasbourg for a
        prosthetic-joint infection (knee or hip) treated by replacement
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults ( &gt; 18 years-old) hospitalized from 1st January 2018 to 31th December 2018 in
             the septic orthopedic surgery unity of the university hospital of Strasbourg for a
             prosthetic-joint infection (knee or hip) treated by replacement.

          -  Patients who mentioned they agree for scientific use of their medical data.

        Exclusion Criteria:

          -  Patients hospitalized only for the second surgery of a two-stage replacement.

          -  Patients who refused or didn't agree with scientific use of their medical data.

          -  Adults with legal protective measures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cécile RONDE-OUSTAU, MD</last_name>
    <phone>33 3 68 76 50 62</phone>
    <email>cecile.ronde-oustau@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Chirurgie Orthopédique Septique</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile RONDE- OUSTAU, MD</last_name>
      <phone>33 3 68 76 50 62</phone>
      <email>cecile.ronde-oustau@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile RONDE- OUSTAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Estelle ROUGIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeannot GAUDIAS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole GREUEZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Yves JENNY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril BOERI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François LEFEBVRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien GODET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 27, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2019</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peri-prosthetic infection</keyword>
  <keyword>Joint infection</keyword>
  <keyword>One-stage replacement</keyword>
  <keyword>Broad-spectrum β -lactam</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

